In our study, OGM provided a very precise molecular description of a BCR::ABL1-positive B-ALL case (#03), detecting deletions in IKZF1, PAX5, BTG1, ADD3, CDKN2A, and KRAS genes. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.